Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of the Efficacy and Safety of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors

NCT05707910 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT05707910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05707910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of the Efficacy and Safety of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors
Lead sponsor
West China Hospital
Phase
Phase 1
Overall status
Active, not recruiting
Start date
February 8, 2023
Completion date
December 31, 2027
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant tumor